ADME Study in Healthy Male Subjects With TA-8995

Status:
Completed

Trial end date:
2015-08-01

Target enrollment:

Participant gender:

A study to measure the absorption, metabolism and excretion of a single dose of radiolabelled TA-8995 (10mg) in healthy male subjects.

Phase 1

Xention Ltd